These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29377882)

  • 21. Immune response to the mannose-sensitive hemagglutinin in patients with cholera due to Vibrio cholerae O1 and O0139.
    Qadri F; Jonson G; Begum YA; Wennerås C; Albert MJ; Salam MA; Svennerholm AM
    Clin Diagn Lab Immunol; 1997 Jul; 4(4):429-34. PubMed ID: 9220159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh.
    Akter A; Dash P; Aktar A; Jahan SR; Afrin S; Basher SR; Hakim A; Lisa AK; Chowdhury F; Khan AI; Xu P; Charles RC; Kelly M; Kováč P; Harris JB; Bhuiyan TR; Calderwood SB; Ryan ET; Qadri F
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007634. PubMed ID: 31369553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh.
    Saha D; LaRocque RC; Khan AI; Harris JB; Begum YA; Akramuzzaman SM; Faruque AS; Ryan ET; Qadri F; Calderwood SB
    J Infect Dis; 2004 Jun; 189(12):2318-22. PubMed ID: 15181581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
    García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R
    Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics of the vibriocidal antibody response to live oral cholera vaccines.
    Wasserman SS; Losonsky GA; Noriega F; Tacket CO; Castañeda E; Levine MM
    Vaccine; 1994 Aug; 12(11):1000-3. PubMed ID: 7975839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Simplified vibriocidal antibody titer performed on a drop of blood].
    Bougoudogo F; Fournier JM; Guillou M; Dodin A
    Bull Soc Pathol Exot; 1993; 86(5):329-32. PubMed ID: 7510156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors influencing secondary vibriocidal immune responses: relevance for understanding immunity to cholera.
    Losonsky GA; Yunyongying J; Lim V; Reymann M; Lim YL; Wasserman SS; Levine MM
    Infect Immun; 1996 Jan; 64(1):10-5. PubMed ID: 8557325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitive microplate assay for detection of bactericidal antibodies to Vibrio cholerae O139.
    Attridge SR; Johansson C; Trach DD; Qadri F; Svennerholm AM
    Clin Diagn Lab Immunol; 2002 Mar; 9(2):383-7. PubMed ID: 11874883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying Recent Cholera Infections Using a Multiplex Bead Serological Assay.
    Jones FK; Bhuiyan TR; Muise RE; Khan AI; Slater DM; Hutt Vater KR; Chowdhury F; Kelly M; Xu P; Kováč P; Biswas R; Kamruzzaman M; Ryan ET; Calderwood SB; LaRocque RC; Lessler J; Charles RC; Leung DT; Qadri F; Harris JB; Azman AS
    mBio; 2022 Dec; 13(6):e0190022. PubMed ID: 36286520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucosal and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria.
    Viret JF; Favre D; Wegmüller B; Herzog C; Que JU; Cryz SJ; Lang AB
    Infect Immun; 1999 Jul; 67(7):3680-5. PubMed ID: 10377160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Seroepidemiology of cholera in Mexico].
    González-Bonilla C; Valle-Valdez JG; Núñez-León A; Moguel-Pech L; Villanueva-Zamudio A
    Rev Latinoam Microbiol; 1994; 36(4):253-6. PubMed ID: 7701134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serologic studies of naturally acquired infection with Vibrio cholerae serogroup O1 in the United States.
    Snyder JD; Allegra DT; Levine MM; Craig JP; Feeley JC; DeWitt WE; Blake PA
    J Infect Dis; 1981 Feb; 143(2):182-7. PubMed ID: 7194358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibacterial and antitoxin responses in the serum and milk of cholera patients.
    Majumdar AS; Dutta P; Dutta D; Ghose AC
    Infect Immun; 1981 Apr; 32(1):1-8. PubMed ID: 7216479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guinea pig complement potently measures vibriocidal activity of human antibodies in response to cholera vaccines.
    Kim KW; Jeong S; Ahn KB; Yang JS; Yun CH; Han SH
    J Microbiol; 2017 Dec; 55(12):973-978. PubMed ID: 29214494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase 1 evaluation of Vibrio cholerae O1, serotype Inaba, polysaccharide-cholera toxin conjugates in adult volunteers.
    Gupta RK; Taylor DN; Bryla DA; Robbins JB; Szu SC
    Infect Immun; 1998 Jul; 66(7):3095-9. PubMed ID: 9632571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A population-based serological survey of
    Clutter CH; Klarman MB; Cajusma Y; Cato ET; Sayeed A; Brinkley L; Jensen O; Baril C; De Rochars VMB; Azman AS; Long MT; Cummings D; Leung DT; Nelson EJ
    medRxiv; 2023 Feb; ():. PubMed ID: 36798289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A duplex vibriocidal assay to simultaneously measure bactericidal antibody titers against Vibrio cholerae O1 Inaba and Ogawa serotypes.
    Yang JS; Choi S; Kim DD; Kang SS; Yun CH; Lee K; Han SH
    J Microbiol Methods; 2009 Dec; 79(3):289-94. PubMed ID: 19796659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM
    Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction in capsular content and enhanced bacterial susceptibility to serum killing of Vibrio cholerae O139 associated with the 2002 cholera epidemic in Bangladesh.
    Qadri F; Svennerholm AM; Shamsuzzaman S; Bhuiyan TR; Harris JB; Ghosh AN; Nair GB; Weintraub A; Faruque SM; Ryan ET; Sack DA; Calderwood SB
    Infect Immun; 2005 Oct; 73(10):6577-83. PubMed ID: 16177333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroepidemiology of cholera in Gulf coastal Texas.
    Hunt MD; Woodward WE; Keswick BH; Dupont HL
    Appl Environ Microbiol; 1988 Jul; 54(7):1673-7. PubMed ID: 3415232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.